Mauna Kea Technologies SA
PAR:ALMKT

Watchlist Manager
Mauna Kea Technologies SA Logo
Mauna Kea Technologies SA
PAR:ALMKT
Watchlist
Price: 0.1284 EUR -3.17% Market Closed
Market Cap: €22.5m

Relative Value

The Relative Value of one ALMKT stock under the Base Case scenario is 0.1428 EUR. Compared to the current market price of 0.1284 EUR, Mauna Kea Technologies SA is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALMKT Relative Value
Base Case
0.1428 EUR
Undervaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

ALMKT Competitors Multiples
Mauna Kea Technologies SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Mauna Kea Technologies SA
PAR:ALMKT
23.2m EUR 3.1 -2.2 -8.1 -5.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD 19.5 68.3 52.1 63.6
US
Abbott Laboratories
NYSE:ABT
184.6B USD 4.2 13.2 16.9 23.5
US
Boston Scientific Corp
NYSE:BSX
135.6B USD 7 48.6 28.5 38.7
US
Stryker Corp
NYSE:SYK
134.5B USD 5.5 45.7 22.3 27
IE
Medtronic PLC
NYSE:MDT
128.9B USD 3.7 27.1 15.2 22
US
Becton Dickinson and Co
NYSE:BDX
57B USD 2.6 34.2 12.6 21.4
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR 2.1 22.5 12.8 18
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD 13.3 53.9 38.8 42.9
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD 8.2 35.4 25.3 27.7
US
Resmed Inc
NYSE:RMD
36.6B USD 7 25.4 18.2 20.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Mauna Kea Technologies SA
PAR:ALMKT
Average EV/EBITDA: 24.3
Negative Multiple: -8.1
N/A N/A
US
Intuitive Surgical Inc
NASDAQ:ISRG
52.1
26%
2
US
Abbott Laboratories
NYSE:ABT
16.9
12%
1.4
US
Boston Scientific Corp
NYSE:BSX
28.5
22%
1.3
US
Stryker Corp
NYSE:SYK
22.3
13%
1.7
IE
Medtronic PLC
NYSE:MDT
15.2
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.6
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.8
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.8
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.3
13%
1.9
US
Resmed Inc
NYSE:RMD
18.2
11%
1.7